PET scans reveal Drug's gut impact in Crohn's
NCT ID NCT06432764
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 22 times
Summary
This study tested a new drug (AZD7798) in 9 adults with Crohn's disease to see how it changes inflammation in the small intestine. Researchers used special PET scans to measure these changes. The goal was to understand how the drug works in the body, not to treat the disease directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Stockholm, 14186, Sweden
Conditions
Explore the condition pages connected to this study.